Oncolytic viruses and histone deacetylase inhibitors—A multi-pronged strategy to target tumor cells
To access this article, please choose from the options below
PII: S1359-6101(10)00027-4
doi:10.1016/j.cytogfr.2010.03.002
© 2010 Elsevier Ltd. All rights reserved.
